Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 650x65px
All >

News > Switzerland

Total search results: 2247 | Ordered by Date (descending)
next pagenext page 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
ThromboGenics N.V.. (3/15/13). "Press Release: ThromboGenics’ Jetrea Granted EU Approval for Vitreomacular Traction (VMT), including when Associated with Macular Hole of Diameter Less than or Equal to 400 Microns". Leuven. 2013-03-15
AB Sciex. (3/14/13). "Press Release: AB Sciex Announces 5th Berliner LC/MS/MS Symposium, April 9th, Berlin". Darmstadt. 2013-03-14
Hyglos GmbH. (3/14/13). "Press Release: Lonza and Hyglos GmbH Reach Agreement for Endotoxin Detection Patents". Walkersville, MD & Munich. 2013-03-14
Biocartis S.A.. (3/12/13). "Press Release: Biocartis Strengthens Management Team with Chief Medical Officer". Lausanne & Mechelen. 2013-03-12
Cytos Biotechnology AG. (3/12/13). "Press Release: Cytos Biotechnology Strengthens Management Team". Schlieren. 2013-03-12
Galenica. (3/12/13). "Press Release: Profits up for the 17th Consecutive Year in 2012: +13.6% after Minority Interests". Bern. 2013-03-12
Auven Therapeutics Management L.L.L.P.. (3/11/13). "Press Release: Celtic Therapeutics Rebrands as Auven Therapeutics". US Virgin Islands, NY & Lausanne. 2013-03-11
Ares Life Sciences. (3/8/13). "Press Release: Ares Life Sciences to Acquire Greer Laboratories, Inc., a Leader in Allergy Immunotherapy in the United States". Geneva. 2013-03-08
Tecan Group Ltd.. (3/7/13). "Press Release: Tecan Posts a Solid Performance in 2012 and an Acceleration in Sales in the Second Half. Financial Results – Full-year and Second Half of 2012". Männedorf. 2013-03-07
Tecan Group Ltd.. (3/7/13). "Press Release: Tecan’s OEM Partner Dako Unveils New Platform at Global Congress". Männedorf. 2013-03-07
Evolva Holding S.A.. (3/6/13). "Press Release: Evolva and Cargill in Deal to Co-develop Steviol Glycosides. Collaboration Lays Foundation for Next Evolution in Stevia Industry". Reinach. 2013-03-06
GlycoVaxyn AG. (3/6/13). "Press Release: GlycoVaxyn AG Announces Addition of Gerd Zettlmeissl, as Chairman of the Board of Directors". Zürich-Schlieren. 2013-03-06
Roche. (3/6/13). "Press Release: FDA Approves New Roche Test to Evaluate Response to Hepatitis C Therapy. Viral Load Test Uses a Novel Dual-probe Approach Designed to Manage Patients Being Treated with Antiviral Therapies". Basel. 2013-03-06
MorphoSys AG. (3/5/13). "Press Release: MorphoSys AG Reports Results for Fiscal Year 2012". 2013-03-05
Roche. (3/5/13). "Press Release: Roche Annual General Meeting 2013. 26th Dividend Increase in Succession – Election/Re-election of All Members of the Board of Directors Nominated". Basel. 2013-03-05
Roche. (3/5/13). "Press Release: Roche Chairman Franz B. Humer Announces that He Will Not Stand for Re-election in 2014. Roche to Inform about Plans for Succession in Autumn 2013". Basel. 2013-03-05
Roche. (3/5/13). "Press Release: Roche Obtains EU Approval for Perjeta, a New Personalised Treatment for Aggressive Type of Breast Cancer". Basel. 2013-03-05
Addex Therapeutics S.A.. (3/4/13). "Press Release: Addex Partners with Viva Biotech to Advance Allosteric Modulators Targeting Adenosine 2A Receptor". Geneva. 2013-03-04
Bayer AG. (3/1/13). "Press Release: New Mode of Action for Effective Soybean Weed Control. Bayer CropScience and Syngenta Submit Herbicide-tolerance Soybean Trait for Approval in Various Countries". Monheim. 2013-03-01
Novartis AG. (3/1/13). "Press Release: Novartis Receives EU Approval for Ilaris in Patients Suffering Acute Gouty Arthritis Attacks Who Cannot Gain Relief from Current Treatments". Basel. 2013-03-01
Addex Therapeutics S.A.. (2/28/13). "Press Release: Addex Therapeutics Reports 2012 Financial Results". Geneva. 2013-02-28
BioGenes GmbH. (2/28/13). "Press Release: BioGenes Reports Strong Growth of HCP Assay Development Business. Company Is Developing Pre-optimized HCP Assay Kits". Berlin. 2013-02-28
Tecan Group Ltd.. (2/28/13). "Press Release: Tecan Appoints Dr. Stefan Traeger to the Management Board". Männedorf. 2013-02-28
Advion, Inc.. (2/26/13). "Press Release: Advion and CAMAG Form Exclusive Alliance to Commercialize Unique TLC/CMS Assay System for Synthetic Organic and Peptide Chemists". Ithaca, NY & Muttenz. 2013-02-26
Okairos AG. (2/25/13). "Press Release: Okairos Initiates Phase I Clinical Trial Evaluating Vaccine against RSV Infections". Basel. 2013-02-25
Selexis S.A.. (2/20/13). "Press Release: Selexis Announces Expansion of R&D License Agreement with Amgen. Expansion to Include the Selexis SURE CHO-M Cell Line". Geneva. 2013-02-20
Biognosys AG. (2/19/13). "Press Release: Plasma Glycoproteome Analysis in Clinical Biomarker Research". 2013-02-19
Roche. (2/18/13). "Press Release: Roche and Chiasma Announce Collaboration to Develop and Commercialize Chiasma’s Octreolin for Acromegaly and Neuroendocrine Tumors". Basel. 2013-02-18
Novartis AG. (2/15/13). "Press Release: Novartis Drug Zortress Is First in Over a Decade Approved by FDA to Prevent Organ Rejection in Adult Liver Transplant Patients". Basel. 2013-02-15
Cytos Biotechnology AG. (2/14/13). "Press Release: Cytos Biotechnology Announces Full Year 2012 Financial Results". Schlieren. 2013-02-14
Geneva Bioinformatics (GeneBio) S.A.. (2/12/13). "Press Release: The SIB Swiss Institute of Bioinformatics, GeneBio and Quartz Bio Unveil a Collaboration on MegaClust". 2013-02-12
Piqur Therapeutics AG. (2/11/13). "Press Release: Piqur Secured Funding to Start the Development of Innovative Anti-cancer Therapies. Successful Spin-off of the University of Basel". 2013-02-11
Genedata AG. (2/7/13). "Press Release: Ono Pharmaceutical Selects Genedata Expressionist for Mass Spectrometry". Basel & Tokyo. 2013-02-07
Addex Therapeutics S.A.. (2/7/13). "Press Release: Addex to Focus Resources on Clinical Pipeline". Geneva. 2013-02-07
Lonza Group Ltd.. (2/4/13). "Press Release: Lonza to Adapt Its Management Structure to Focus on Target Markets and Improve Profitability". Basel. 2013-02-04
Cryo-Save Group N.V.. (2/1/13). "Press Release: Cryo-Save Strenthens Management with Chief Commercial Officer". 2013-02-01
Roche. (1/30/13). "Press Release: Roche Delivers Strong 2012 Results". Basel. 2013-01-30
Tecan Group Ltd.. (1/30/13). "Press Release: Tecan CEO David Martyr Forms New Leadership Team". Männedorf. 2013-01-30
Sartorius AG. (1/29/13). "Press Release: Sartorius Stedim Biotech. Successful Fiscal 2012 – New Highs in Sales Revenue and Earnings – Positive Outlook for 2013". 2013-01-29
4-Antibody AG. (1/29/13). "Press Release: 4-Antibody AG and the Ludwig Institute Expand Oncology Antibody R&D Program with Three New Targets". Basel & New York, NY. 2013-01-29
Addex Therapeutics S.A.. (1/29/13). "Press Release: Addex Dipraglurant Reduces Motor Abnormalities in a Preclinical Model Relevant for Several Rare Types of Dystonia". Geneva. 2013-01-29
Biognosys AG. (1/23/13). "Press Release: Biognosys Announces Spectronaut Software Launch". Zürich-Schlieren. 2013-01-23
Merck Serono. (1/23/13). "Press Release: Merck Serono Announces the Creation of Ondaco, the Fifth Company Stemming From Its Entrepreneur Partnership Program". Geneva. 2013-01-23
Bayer AG. (1/23/13). "Press Release: Dr. Jörg Reinhardt to Leave Bayer HealthCare". Leverkusen. 2013-01-23
Cytos Biotechnology AG. (1/23/13). "Press Release: Cytos to Regain Rights to Smoking Cessation Vaccine". Schlieren. 2013-01-23
Addex Therapeutics S.A.. (1/22/13). "Press Release: Addex Announces Issuance of a Broad US Composition of Matter Patent for ADX71441". Geneva. 2013-01-22
Novartis AG. (1/22/13). "Press Release: Novartis Receives EU Approval for Bexsero, First Vaccine to Prevent the Leading Cause of Life-threatening Meningitits across Europe". Basel. 2013-01-22
ETH Zürich. (1/21/13). "Pressemitteilung: Exakte Karte für das Hefe-Proteom". 2013-01-21
BB Biotech AG. (1/16/13). "Press Release: BB Biotech AG Earns After-tax Profits of CHF 368 Million in Fiscal 2012". 2013-01-16
Cytos Biotechnology AG. (1/16/13). "Press Release: Cytos Provides Update of Phase 2b Clinical Trial of CYT003 in Allergic Asthma. Guidance for Top-line Results in 1H 2014 Reiterated". Schlieren. 2013-01-16
Debiopharm S.A.. (1/9/13). "Press Release: Spinomix Closes a $ 3 Million Financing Round Led by Debiopharm Group". Lausanne. 2013-01-09
Lonza Group Ltd.. (1/8/13). "Press Release: Lonza to Expand Antibody Drug Conjugate (ADC) Manufacturing Capacity to Meet Growing Customer Demand". Basel. 2013-01-08
Debiopharm S.A.. (1/8/13). "Press Release: Chugai and Debiopharm Group Announce an Exclusive License Agreement for Anti-cancer Agent FF284 (Debio 1347)". Lausanne & Tokyo. 2013-01-08
Addex Therapeutics S.A.. (1/7/13). "Press Release: Addex Announces Positive Data with ADX71441 in a Pre-clinical Transgenic Model of Charcot-Marie-Tooth 1A Disease". Geneva. 2013-01-07
Lonza Group Ltd.. (12/28/12). "Press Release: Lonza Completes the Divestiture of Its Brandenburg, KY Performance Urethanes and Organics Business to Monument Chemical". Basel & Indianapolis, IN. 2012-12-28
Novartis AG. (12/21/12). "Press Release: Novartis Drug Exjade Approved by European Commission for Iron Overload in Patients with Non-transfusion-dependent Thalassemia". Basel. 2012-12-21
Octpaharma AG. (12/21/12). "Press Release: Octapharma Wins Major Tender Victory in Norway". Lachen. 2012-12-21
Addex Therapeutics S.A.. (12/20/12). "Press Release: Addex Scientists Discover and Characterize the First Potent and Selective Small Molecule Negative Allosteric Modulator Targeting mGlu7 Receptor". Geneva. 2012-12-20
Evolva Holding S.A.. (12/20/12). "Press Release: Evolva Successfully Discussed Clinical Development Plans for EV-077 in Diabetes Patients with German Regulatory Authority". Reinach. 2012-12-20
Lonza Group Ltd.. (12/19/12). "Press Release: Lonza and Sartorius Stedim Biotech Enter Collaboration, Supply and Distribution Agreement in the Field of Cell Culture Media". Basel. 2012-12-19
Basilea Pharmaceutica Ltd.. (12/14/12). "Press Release: Basilea Reports Recruitment Completion of Phase 3 Pivotal Study of Isavuconazole, an Agent for the Potential Primary Treatment of Invasive and Life-threatening Fungal Infections". Basel. 2012-12-14
Biocartis S.A.. (12/12/12). "Press Release: Biocartis Completes €34.5 Million ($44.5 Million) Series D Fund Raising". Lausanne. 2012-12-12
Basilea Pharmaceutica Ltd.. (12/10/12). "Press Release: Basilea Appoints Ronald Scott as CEO to Succeed Anthony Man and Expands Management Team". Basel. 2012-12-10
Biognosys AG. (12/7/12). "Press Release: Closing of Financing Round and New CEO". 2012-12-07
Uniqure B.V.. (12/6/12). "Press Release: Uniqure Appoints Hans Christian Rohde Chief Commercial Officer". Amsterdam. 2012-12-06
Roche. (12/5/12). "Press Release: Roche and the Innovative Medicines Initiative Join Forces to Promote Use of Nobel Prize-winning Stem Cell Technology to Enhance Drug Development". Basel. 2012-12-05
Biocartis S.A.. (12/5/12). "Press Release: Biocartis Announces Commercial Launch of a New Biomarker Analysis Platform". Lausanne. 2012-12-05
Lonza Group Ltd.. (11/29/12). "Press Release: Lonza Signs Definitive Agreement for the Sale of Brandenburg, KY Performance Urethanes and Organics Business to Monument Chemical". Basel & Indianapolis, IN. 2012-11-29
Roche. (11/28/12). "Press Release: Roche and the Broad Institute Collaborate to Identify Novel Uses for Advanced Compounds". Nutley, NJ & Cambridge, MA. 2012-11-28
Tecan Group Ltd.. (11/27/12). "Press Release: Tecan Launches AlphaScreen Option for Infinite F200 Pro Reader". Männedorf. 2012-11-27
Actelion Ltd.. (11/22/12). "Press Release: Actelion Submits the Registration Dossier for Macitentan (Opsumit) to the European Medicines Agency (EMA)". Allschwil. 2012-11-22
Basilea Pharmaceutica Ltd.. (11/22/12). "Press Release: Basilea Initiates Next Phase 1 Multiple Ascending Dose Study with Antibiotic BAL30072 Active against Multidrug-resistant Gram-negative Bacteria". Basel. 2012-11-22
Evolva Holding S.A.. (11/21/12). "Press Release: Evolva Selected to Acquire Certain Fluxome Assets". Reinach. 2012-11-21
Novartis AG. (11/20/12). "Press Release: Novartis Receives FDA Approval for Flucelvax, the First Cell-culture Vaccine in US to Help Protect against Seasonal Influenza". Basel. 2012-11-20
DKFZ (Deutsches Krebsforschungszentrum). (11/16/12). "Press Release: Sciene and Industry Join Forces to Optimize Cancer Treatment". 2012-11-16
Tecan Group Ltd.. (11/15/12). "Press Release: Tecan and Promega Offer Variable Volume DNA Isolation. The Freedom EVO – HSM Is a Turnkey Solution for gDNA Extraction". Männedorf. 2012-11-15
Genedata AG. (11/14/12). "Press Release: LifeTech TaqMan Assays Integrate with Genedata Expressionist for Genomic Profiling. Genedata Partners with Life Technologies to Expedite NGS Data Analysis and Real-time PCR-based Validation". Basel. 2012-11-14
Boehringer Ingelheim. (11/12/12). "Press Release: Boehringer Ingelheim Enters Strategic Collaboration Agreement to Support Molecular Partners’ Proprietary Pipeline with Clinical Supply of DARPin Molecules". Ingelheim & Schlieren. 2012-11-12
Lonza Group Ltd.. (11/12/12). "Press Release: Lonza Introduces Fresh Human Pancreatic Islets". Basel & Cologne. 2012-11-12
Novartis AG. (11/9/12). "Press Release: Novartis Announces Update to Company’s Board of Directors to Take Effect in February 2013". Basel. 2012-11-09
Evotec AG. (11/8/12). "Press Release: Evotec Reports 8% Revenue Growth and a Positive Operating Result of EUR2.9 m in the First Nine Months of 2012". Hamburg. 2012-11-08
Evotec AG. (11/8/12). "Press Release: Q3 Presentation. Action Plan 2016 – Gaining Momentum". Hamburg. 2012-11-08
Medigene AG. (11/8/12). "Press Release: Medigene Announces Market Launch of Veregen in Switzerland and Market Approval in 8 Additional European Countries". Martinsried. 2012-11-08
Novartis AG. (11/8/12). "Press Release: Novartis Future Growth Prospects Secured by Industry-leading Pipeline, with More than 139 Projects with 73 New Compounds". Basel. 2012-11-08
MorphoSys AG. (11/7/12). "Press Release: MorphoSys Announces Expansion of Antibody Alliance. Collaboration to Benefit from Access to Newest Technologies". 2012-11-07
Roche. (11/7/12). "Press Release: Roche Introduces New GS FLX+ Software for Significantly Improved Long-read Sequencing Performance". Branford, CT & Penzberg. 2012-11-07
Genedata AG. (11/6/12). "Press Release: Genedata Biologics for Streamlined Protein Engineering at PEGS Europe. UCB Pharma and Genedata Will Showcase Data Management and Workflow System". Vienna. 2012-11-06
Roche. (11/6/12). "Press Release: Roche Launches New LightCycler 96 System Enabling Broad Application of Its High-performance PCR Technology in Academic Research". Penzberg. 2012-11-06
Novartis AG. (11/5/12). "Press Release: Novartis Drug Votubia Approved in the EU as First Medication to Treat Patients with Non-cancerous Kidney Tumors Associated with TSC". Basel. 2012-11-05
Lonza Group Ltd.. (10/31/12). "Press Release: Lonza Delivers Solid Performance in Q3, Cost Improvement Programs on Track". Basel. 2012-10-31
Novartis AG. (10/31/12). "Press Release: Novartis to Start Construction of New Biotechnology Facility in Singapore with an Investment of Over USD 500 Million". Singapore. 2012-10-31
Tecan Group Ltd.. (10/30/12). "Press Release: Tecan and TAP Biosystems to Automate RAFT 3D Cell Culturing on the Freedom EVO. The RAFT System Will further Extend the 3D Cell Culturing Capabilities of the Freedom EVO Platform". Männedorf. 2012-10-30
Kymab Ltd.. (10/29/12). "Press Release: Kymab Strengthens Board of Directors with Appointments of Christian Itin, David Chiswell and Richard Davis". Cambridge. 2012-10-29
Novartis AG. (10/25/12). "Press Release: Recently Launched Products Support Novartis Sales in Third Quarter, Offsetting Patent Expiry, Pharmaceuticals Well-positioned with Further Pipeline Progress". Basel. 2012-10-25
Biotecon Diagnostics GmbH. (10/23/12). "Press Release: Biotecon Diagnostics Successfully Finishes a MicroVal Certification Again". Potsdam. 2012-10-23
Lonza Group Ltd.. (10/23/12). "Press Release: Lonza and OncoMed Pharmaceuticals Sign a Process Development and Manufacturing Collaboration and Multi-product GS License Agreement for Anti-cancer Therapeutics". Basel & Redwood City, CA. 2012-10-23
SGS S.A.. (10/22/12). "Press Release: SGS Acquires Sentinel Services (Proprietary) Ltd, South Africa". 2012-10-22
Actelion Ltd.. (10/22/12). "Press Release: Actelion Submits a New Drug Application to the FDA for Macitentan (Opsumit) for the Treatment of Patients with Pulmonary Arterial Hypertension". Allschwil. 2012-10-22
Analytik Jena AG. (10/19/12). "Press Release: New Combustion Module from Analytik Jena Offers Additional Applications for Ion Chromatography". 2012-10-19
Actelion Ltd.. (10/18/12). "Press Release: Actelion Announces Nine Months 2012 Financial Results. Total Product Sales of CHF 1,298.6 Million, Down 3% in Local Currencies". Allschwil. 2012-10-18
next pagenext page 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23  next pagenext page



Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 650x65px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture [LSA] Life-Sciences-Asia.com – The Business Web Portal 650x89px

» top